Loading...
Transthyretin cardiac amyloidosis: an update on diagnosis and treatment
Transthyretin cardiac amyloidosis (ATTR‐CA) demonstrates progressive, potentially fatal, and infiltrative cardiomyopathy caused by extracellular deposition of transthyretin‐derived insoluble amyloid fibrils in the myocardium. Two distinct types of transthyretin (wild type or variant) become unstable...
Na minha lista:
| Udgivet i: | ESC Heart Fail |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6989279/ https://ncbi.nlm.nih.gov/pubmed/31553132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12518 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|